219 related articles for article (PubMed ID: 12954811)
1. Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness.
Quilley J; Qiu Y; Hirt J
J Pharmacol Exp Ther; 2003 Oct; 307(1):223-9. PubMed ID: 12954811
[TBL] [Abstract][Full Text] [Related]
2. Involvement of protein kinase C in reduced relaxant responses to the NO/cyclic GMP pathway in piglet pulmonary arteries contracted by the thromboxane A2-mimetic U46619.
Pérez-Vizcaíno F; Villamor E; Duarte J; Tamargo J
Br J Pharmacol; 1997 Aug; 121(7):1323-33. PubMed ID: 9257910
[TBL] [Abstract][Full Text] [Related]
3. Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase.
Liu CQ; Leung FP; Wong SL; Wong WT; Lau CW; Lu L; Yao X; Yao T; Huang Y
Biochem Pharmacol; 2009 Aug; 78(4):374-81. PubMed ID: 19409373
[TBL] [Abstract][Full Text] [Related]
4. Role of prostanoids and 20-HETE in mediating oxygen-induced constriction of skeletal muscle resistance arteries.
Frisbee JC; Krishna UM; Falck JR; Lombard JH
Microvasc Res; 2001 Nov; 62(3):271-83. PubMed ID: 11678630
[TBL] [Abstract][Full Text] [Related]
5. 20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats.
Frisbee JC; Roman RJ; Falck JR; Krishna UM; Lombard JH
Microcirculation; 2001 Feb; 8(1):45-55. PubMed ID: 11296852
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cyclooxygenase but not nitric oxide synthase influences effects on the human omental artery of the thromboxane A2 mimetic U46619 and 17beta-estradiol.
Vedernikov YP; Belfort MA; Saade GR; Garfield RE
Am J Obstet Gynecol; 2001 Jul; 185(1):182-9. PubMed ID: 11483926
[TBL] [Abstract][Full Text] [Related]
7. The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation.
Randriamboavonjy V; Kiss L; Falck JR; Busse R; Fleming I
Cardiovasc Res; 2005 Feb; 65(2):487-94. PubMed ID: 15639488
[TBL] [Abstract][Full Text] [Related]
8. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats.
Ajayi AA; Ogungbade GO; Okorodudu AO
Eur J Clin Invest; 2004 May; 34(5):349-57. PubMed ID: 15147332
[TBL] [Abstract][Full Text] [Related]
9. Effect of ischemia duration and nitric oxide on coronary vasoconstriction after ischemia-reperfusion.
García-Villalón AL; Amezquita YM; Monge L; Fernández N; Climent B; Sánchez A; Diéguez G
Eur J Pharmacol; 2005 Feb; 509(2-3):165-70. PubMed ID: 15733552
[TBL] [Abstract][Full Text] [Related]
10. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II.
Alonso-Galicia M; Maier KG; Greene AS; Cowley AW; Roman RJ
Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931
[TBL] [Abstract][Full Text] [Related]
11. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong, in rat isolated aorta.
Chan SS; Choi AO; Jones RL; Lin G
Eur J Pharmacol; 2006 May; 537(1-3):111-7. PubMed ID: 16624277
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats.
Zhang F; Deng H; Kemp R; Singh H; Gopal VR; Falck JR; Laniado-Schwartzman M; Nasjletti A
Hypertension; 2005 Jan; 45(1):103-8. PubMed ID: 15569854
[TBL] [Abstract][Full Text] [Related]
14. Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase.
Cheng MK; McGiff JC; Carroll MA
Am J Physiol Renal Physiol; 2003 Mar; 284(3):F474-9. PubMed ID: 12419775
[TBL] [Abstract][Full Text] [Related]
15. Enhancement effect under high-glucose conditions on U46619-induced spontaneous phasic contraction in mouse portal vein.
Nobe K; Sakai Y; Nobe H; Takashima J; Paul RJ; Momose K
J Pharmacol Exp Ther; 2003 Mar; 304(3):1129-42. PubMed ID: 12604690
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of U46619 on renal regional hemodynamics in the rat: involvement of endothelin.
Hantz H; Adesuyi A; Adebayo O
J Pharmacol Exp Ther; 2001 Oct; 299(1):372-6. PubMed ID: 11561101
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450 metabolites of arachidonic acid may be important mediators in angiotensin II-induced vasoconstriction in the rat mesentery in vivo.
Chu ZM; Croft KD; Kingsbury DA; Falck JR; Reddy KM; Beilin LJ
Clin Sci (Lond); 2000 Mar; 98(3):277-82. PubMed ID: 10677385
[TBL] [Abstract][Full Text] [Related]
18. Study of tachyphylaxis to the vasoconstrictor effect of arachidonic acid in the isolated perfused kidney of the rat.
Quilley J; McGiff JC
J Pharmacol Exp Ther; 1990 Jan; 252(1):241-5. PubMed ID: 2105392
[TBL] [Abstract][Full Text] [Related]
19. Role of the cytochrome P450 enzyme system as a humoral modulator of vasomotor responses in rat renal vasculature.
Oyekan AO
J Cardiovasc Pharmacol; 1994 Aug; 24(2):238-46. PubMed ID: 7526055
[TBL] [Abstract][Full Text] [Related]
20. Contributions of nitric oxide and prostanoids and their signaling pathways to the renal medullary vasodilator effect of U46619 (9-11-dideoxy-11 alpha,9a-epoxymethano-prostaglandin F(2a)) in the rat.
Oyekan AO
J Pharmacol Exp Ther; 2003 Feb; 304(2):507-12. PubMed ID: 12538801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
